
3 New Papers: A 5-Day Fasting Protocol Resets Your Gut, Aerobic Exercise Trims Postmenopausal Body Fat, and CBT-I Calms Dementia Behaviors
Three PubMed papers indexed June 1–7, 2026: an n=64 RCT finds a 5-day ~600 kcal/day fast cuts inflammation and shifts gut bacteria (but effects reverse within a month, and industry COI applies); a 16-RCT meta-analysis (n=1,571 postmenopausal women) confirms aerobic training cuts body fat −1.40% and waist −2.02 cm; and a 240-person cluster RCT of CBT-I in nursing homes finds sleep scores don't improve dramatically but agitation, depression, and other dementia behaviors do.

リサーチノート
PubMed papers indexed June 1–7, 2026. This week's three picks: a small but well-designed RCT that tracked what a 5-day modified fast actually does to your microbiome and blood markers (with an important industry-funding caveat), a 16-RCT meta-analysis confirming the body-composition benefits of aerobic exercise in postmenopausal women, and a cluster RCT testing whether a team-delivered sleep therapy could quiet the behavioral symptoms of dementia in nursing home residents.
Nutrition: five days of fasting shifts gut bacteria and cuts inflammation — briefly
The paper: "Health benefits of a five-day at-home modified fasting program: a randomised controlled trial." Genome Medicine, published June 1, 2026. PMID 42226305. DOI 10.1186/s13073-026-01681-3.1
Study design and sample: Two-arm RCT, n=64 healthy adults randomized to a 5-day hypocaloric (~600 kcal/day), ketogenic modified fasting program (MFP) or a control group asked to maintain usual habits. Outcomes assessed at baseline, end of the 5-day fast, after food reintroduction, and one month later. Blood metabolomics (NMR) and gut metagenomics (shotgun sequencing) were included as secondary analyses.
Core finding: The MFP group lost significantly more weight than controls (−0.52 ± 0.03 kg vs. −0.03 ± 0.02 kg, p<0.001). Blood pressure dropped only after food reintroduction rather than during the fast itself (systolic: −0.56 vs. −0.16 mmHg, p<0.05; diastolic: −0.36 vs. −0.01 mmHg, p<0.01). Metabolomics showed reduced chronic inflammation markers, lower blood glucose, and lower coagulation factors. Shotgun metagenomics detected significant changes in 11 bacterial species and the genomic repertoire of 52 carbohydrate-active enzymes (CAZymes), with a shift toward families that break down host-derived glycan substrates. At one month, however, the gut microbiome and blood metabolome differences were no longer statistically different from controls — the effects appear transient unless the fast is repeated.1
Study design rating: RCT, n=64 (modest), healthy adults only (not a disease population).
Peer-review status: Published in Genome Medicine (peer-reviewed, BioMed Central/Springer).
Conflicts of interest: Significant. Four authors (FG, RM, AH, FWT) are employed by Buchinger Wilhelmi Development and Holding GmbH — the organization that commercially operates the fasting program under study. Three other authors (SS, SH, RG) are employed by Lifespin GmbH, the metabolomics analysis provider. Readers should weigh these affiliations when interpreting the results. The remaining authors declared no competing interests.
Actionable takeaway: A 5-day very-low-calorie fast (≈600 kcal/day) can produce modest but measurable improvements in body weight, inflammatory markers, and gut microbiome composition in healthy adults — with most metabolic benefits reversing within a month after returning to normal eating. If you try a structured fasting protocol, the evidence here suggests blood pressure and microbiome benefits mainly emerge after refeeding rather than during the fast, and repeat cycles would be needed to sustain them. Given the industry funding, treat this as suggestive rather than definitive.

Exercise: aerobic training consistently trims fat mass in postmenopausal women
The paper: "Impact of aerobic training on body composition profiles among postmenopausal women with overweight or obesity: a systematic review and dose-response meta-analysis." BMC Sports Science, Medicine and Rehabilitation, published June 6, 2026. PMID 42251396. DOI 10.1186/s13102-026-01778-7.2
Study design and sample: Systematic review and three-level meta-analysis of 16 RCTs, n=1,571 postmenopausal women with overweight or obesity, comparing aerobic exercise training against a non-exercise control. Databases searched through March 8, 2026; PRISMA guidelines followed. Dose-response modeled via restricted cubic splines.
Core finding: Compared to no-exercise controls, aerobic training reduced:
| Outcome | Effect (MD) | Certainty |
|---|---|---|
| Body weight | −2.17 kg | Low |
| BMI | −0.73 kg/m² | Low |
| Body fat percentage | −1.40% | Moderate |
| Fat mass | −1.83 kg | Moderate |
| Waist circumference | −2.02 cm | Moderate |
| Hip circumference | −1.39 cm | Low |
| Lean body mass | +0.72 kg (not significant) | Low |
All significant reductions were at p<0.01 except hip circumference (p=0.04). The dose-response analysis found no clear nonlinear plateau threshold — more aerobic volume did not appear to produce sharply diminishing returns in this dataset, though some spline curves hinted at possible plateau patterns.2
Study design rating: Systematic review + meta-analysis of 16 RCTs (solid). Evidence certainty is "moderate" for body fat % and fat mass, "low" for weight, BMI, and waist — partly due to variability in exercise protocols and lack of dietary control across trials.
Peer-review status: Published in BMC Sports Science, Medicine and Rehabilitation (peer-reviewed).
Conflicts of interest: None declared.
Actionable takeaway: For postmenopausal women managing body weight and cardiovascular risk, any structured aerobic training program is backed by moderate-certainty evidence to cut body fat percentage by about 1.4 percentage points and waist circumference by about 2 cm relative to not exercising. The analysis did not identify a clear minimum or optimal dose, suggesting that getting started matters more than hitting a specific volume target. Lean mass gains remain uncertain — consider pairing aerobic sessions with resistance training if preserving muscle is a priority.

Sleep: CBT-I in nursing homes doesn't dramatically fix sleep scores, but it quiets dementia-related behaviors
The paper: "The effectiveness of a cognitive behavioural therapy for insomnia based intervention to improve sleep quality in nursing home residents, a cluster randomised controlled trial." European Geriatric Medicine, published June 5, 2026. PMID 42247204. DOI 10.1007/s41999-026-01519-6.3
Study design and sample: Cluster RCT conducted in 5 Belgian nursing homes (February 2024–February 2025), n=240 residents (mean age 86.8 years, 72.5% women). Residents split into two sub-populations: cognitively intact or mildly impaired (PSQI group, n=124) and those with significant cognitive or language impairment (NPI-NH group, n=116). The intervention was a structured, team-delivered program based on CBT-I principles, covering sleep restriction, stimulus control, sleep hygiene, and relaxation.
Core finding: For the PSQI group, there was a statistically significant time×group interaction on total PSQI score (p=0.031), meaning the trajectory of sleep quality improvement differed between intervention and control over time. But at the follow-up assessment, the between-group difference was not statistically significant. In the NPI-NH (dementia) group, no significant sleep effect emerged (p=0.061). The clearer finding came from the neuropsychiatric domain: intervention-group residents showed significant reductions in delusions, agitation/aggression, depression, disinhibition, and aberrant motor behavior.3
Study design rating: Cluster RCT across 5 facilities (n=240); the small number of clusters is a known limitation for cluster-randomized designs, which may inflate some within-cluster effects. Trial was registered (ISRCTN50844606).
Peer-review status: Published in European Geriatric Medicine (peer-reviewed, Springer).
Conflicts of interest: None declared.
Actionable takeaway: Structured CBT-I programs in nursing homes didn't produce a clear endpoint improvement in sleep scores relative to controls in this trial, but they did reduce behavioral symptoms that are among the hardest aspects of dementia for both residents and caregivers — agitation, aggression, depression. If you have a loved one in long-term care, advocating for a structured, team-based sleep hygiene and CBT-I program may be worth it less for sleep per se and more for the downstream behavioral benefits. For sleep-medicine practitioners, this supports treating sleep as a lever for BPSD management, even when polysomnographic or questionnaire outcomes remain modest.
Papers indexed on PubMed between June 1 and June 7, 2026. Study design and sample sizes as reported in abstracts; full-text details may vary.
このコンテンツについて、さらに観点や背景を補足しましょう。